Arrowstreet Capital, Limited Partnership Obs Eva Sa Transaction History

Arrowstreet Capital, Limited Partnership

  • $114 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$2.56 - $3.35 $261,424 - $342,098
-102,119 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$2.01 - $5.05 $35,526 - $89,258
17,675 Added 20.93%
102,119 $332,000
Q3 2020

Nov 12, 2020
SELL
$2.46 - $6.15 $84,132 - $210,330
-34,200 Reduced 28.83%
84,444 $209,000
Q2 2020

Aug 12, 2020
BUY
$2.01 - $5.95 $238,474 - $705,931
118,644 New
118,644 $699,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email